How structural racism and discrimination affect breast cancer survival
Official title: Social Genomic Mechanisms Linking Structural Racism, Perceived Discrimination, and Breast Cancer Survival
Funded at Sloan-Kettering Inst Can Research · NIH-10860344 · Data updated 2026-11-12
This study is looking at how experiences of racism and discrimination might affect breast cancer survival for women living in neighborhoods that have faced historical unfair treatment, and it hopes to find out how these social factors can influence their health and immune responses.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $582,548 |
| NIH project number | 1R37CA288502-01 |
| Project ID | NIH-10860344 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with breast cancer who reside in historically redlined neighborhoods and have experienced perceived discrimination.
✕Less likely to help
Patients who do not have breast cancer or who live outside of historically redlined neighborhoods may not benefit from this research.
What this research studies
This research investigates the impact of structural racism and perceived discrimination on breast cancer survival rates among women living in historically redlined neighborhoods. It aims to uncover the biological mechanisms that may contribute to shorter recurrence-free survival in these populations, despite receiving guideline-concordant treatments. By analyzing blood and tissue samples from a diverse cohort, the study will explore how social factors influence immune responses and cancer biology. The findings could lead to a better understanding of health disparities and inform targeted interventions.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and support systems for breast cancer patients affected by structural racism and discrimination.
How similar studies have gone: Other research has indicated that social determinants of health can significantly impact cancer outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Goel, Neha — Sloan-Kettering Inst Can Research
- Study coordinator: Goel, Neha
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.